# A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa

> clinical trial · VERIFIED · 2026-06-18

Status: RECRUITING · Sponsor: Kiora Pharmaceuticals, Inc. · Condition: Retinitis Pigmentosa

- Company: Kiora Pharmaceuticals, Inc.
- Sector: ophthalmology
- Primary source: https://clinicaltrials.gov/study/NCT06628947

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.